FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Finn Sellebjerg

Research Profile

Disorders

Chemicals & Drugs

Procedures

Anatomy

Concepts & Ideas

Co-author Network

Publications

TOP 3
Finn Sellebjerg; Hans Søndergaard; D Hesse; Martin Krakauer; S Limborg; H Lund; P S Sørensen
Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosis.
Inger-Lise Mero; Aslaug Muggerud; Kjell-Morten Myhr; Tomas Olsson; Annette Oturai; Hanne S Sæther; Finn Sellebjerg; Hans Søndergaard; Jan H Aarseth; Lars Alfredsson; Bettina Kulle Andreassen; Tone Berge; Pål Berg-Hansen; Anja Bjølgerud; Elisabeth Gulowsen Celius; Siri T Flåm; Marte W Gustavsen; Jan Hillert; Poul Erik H Jensen; Ingrid Kockum; Benedicte A Lie; Hanne F Harbo
Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles.
Jeppe Romme Christensen; Mohsen Khademi; Tomas Olsson; Fredrik Piehl; Rikke Ratzer; Lars Börnsen; Per Soelberg Sørensen; Finn Sellebjerg
Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Finn Sellebjerg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Finn Sellebjerg; Hans Søndergaard; D Hesse; Martin Krakauer; S Limborg; H Lund; P S Sørensen
Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2013;19(2):179-87.
2013: Inger-Lise Mero; Aslaug Muggerud; Kjell-Morten Myhr; Tomas Olsson; Annette Oturai; Hanne S Sæther; Finn Sellebjerg; Hans Søndergaard; Jan H Aarseth; Lars Alfredsson; Bettina Kulle Andreassen; Tone Berge; Pål Berg-Hansen; Anja Bjølgerud; Elisabeth Gulowsen Celius; Siri T Flåm; Marte W Gustavsen; Jan Hillert; Poul Erik H Jensen; Ingrid Kockum; Benedicte A Lie; Hanne F Harbo
Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles.
PloS one 2013;8(3):e58352.
2013: Jeppe Romme Christensen; Mohsen Khademi; Tomas Olsson; Fredrik Piehl; Rikke Ratzer; Lars Börnsen; Per Soelberg Sørensen; Finn Sellebjerg
Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression.
PloS one 2013;8(3):e57820.
2013: Henrik Lund; Olaf B Paulson; Finn Sellebjerg; Hartwig R Siebner; Arnold Skimminge; E Garde; Dan Hesse; Martin Krakauer; Lars G Hanson
Blood-brain barrier permeability of normal appearing white matter in relapsing-remitting multiple sclerosis.
PloS one 2013;8(2):e56375.
2012: Morten Blinkenberg; S Lövgaard; O B Paulson; Finn Sellebjerg; H R Siebner; H Sillesen; P Akeson; Per Soelberg Sørensen
Chronic cerebrospinal venous insufficiency and venous stenoses in multiple sclerosis.
Acta neurologica Scandinavica 2012;126(6):421-7.
2012: Finn Sellebjerg; Mohsen Khademi; Martin Krakauer; T Olsson; Per Soelberg Sørensen
FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4(+) CD25(high) T cells in multiple sclerosis.
Clinical and experimental immunology 2012;170(2):149-55.
2012: P E H Jensen; Finn Sellebjerg; Hans Søndergaard; Per Soelberg Sørensen
Correlation between anti-interferon-β binding and neutralizing antibodies in interferon-β-treated multiple sclerosis patients.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2012;19(10):1311-7.
2012: Poul Erik H Jensen; Nils Koch-Henriksen; Finn Sellebjerg; Per S Sørensen
Prediction of antibody persistency from antibody titres to natalizumab.
Multiple sclerosis (Houndmills, Basingstoke, England) 2012;18(10):1493-9.
2012: P Braendstrup; Annika Reynberg Langkilde; Mads Ravnborg; K Schreiber; Finn Sellebjerg; L Vindeløv
Progression and CSF Inflammation after Eradication of Oligoclonal Bands in an MS Patient Treated with Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma.
Case reports in neurology 2012;4(2):101-6.
2012: Finn Sellebjerg; C J Hedegaard; Hans Søndergaard; D Hesse; Martin Krakauer; H Lund; C H Nielsen; P S Sørensen
Glatiramer acetate antibodies, gene expression and disease activity in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2012;18(3):305-13.
2012: Daniel Kondziella; Ingelise Christiansen; Peter Gideon; Teresa Gonzalez; Klaus Hansen; Finn Sellebjerg
[Anti-thyroid antibodies in two patients with subacute dementia, ataxia, and myoclonus].
Ugeskrift for laeger 2012;174(9):577-9.
2012: Lars Börnsen; Jeppe Romme Christensen; Annette Oturai; Rikke Ratzer; Hans Søndergaard; Per Soelberg Sørensen; Finn Sellebjerg
Effect of natalizumab on circulating CD4+ T-cells in multiple sclerosis.
PloS one 2012;7(11):e47578.
2012: Jeppe Romme Christensen; Lars Börnsen; Dan Hesse; Martin Krakauer; Hans Søndergaard; Per Soelberg Sørensen; Finn Sellebjerg
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis.
Journal of neuroinflammation 2012;9():215.
2012: Finn Sellebjerg; Hans Søndergaard; Dan Hesse; Martin Krakauer; Annika Reynberg Langkilde; Signe Limborg; Henrik Lund; Per Soelberg Sørensen
Endogenous and recombinant type I interferons and disease activity in multiple sclerosis.
PloS one 2012;7(6):e35927.
2011: Helle Bach Søndergaard; Per Soelberg Sørensen; Finn Sellebjerg; Lars Börnsen; Elisabeth Gulowsen Celius; Jeppe Romme Christensen; Hanne F Harbo; Jan Hillert; Ingrid Kockum; Magdalena Lindén; Inger-Lise Mero; Kjell-Morten Myhr; Tomas Olsson; Annette Oturai
Alterations in KLRB1 gene expression and a Scandinavian multiple sclerosis association study of the KLRB1 SNP rs4763655.
European journal of human genetics : EJHG 2011;19(10):1100-3.
2011: Per Soelberg Sørensen; Christian Vedeler; Poul Erik Hyldgaard Jensen; Anna Fogdell-Hahn; Aiden Haghikia; Jan Hillert; Nils Koch-Henriksen; Malin Lundkvist; Kjell-Morten Myhr; Finn Sellebjerg; Ralf Gold
Occurrence of antibodies against natalizumab in relapsing multiple sclerosis patients treated with natalizumab.
Multiple sclerosis (Houndmills, Basingstoke, England) 2011;17(9):1074-8.
2011: Per Soelberg Sorensen; Egon Stenager; Xingchen Wu; Astrid Edland; Juha-Pekka Erälinna; Jette Lautrup Frederiksen; Jan Lycke; Clas Malmeström; Annette Oturai; Finn Sellebjerg; H Sondergaard
Simvastatin as add-on therapy to interferon β-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial.
Lancet neurology 2011;10(8):691-701.
2011: João Carlos Correia de Sa; Nikolaos Grigoriadis; Laura Airas; Emmanuel Bartholome; Heinrich Mattle; Celia Oreja-Guevara; Jonathan O'Riordan; Finn Sellebjerg; Bruno Stankoff; Karl Vass; Agata Walczak; Heinz Wiendl; Bernd C Kieseier
Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice.
Therapeutic advances in neurological disorders 2011;4(3):139-68.
2011: Chris J Hedegaard; Finn Sellebjerg; Martin Krakauer; Dan Hesse; Klaus Bendtzen; Claus H Nielsen
Interferon-beta increases systemic BAFF levels in multiple sclerosis without increasing autoantibody production.
Multiple sclerosis (Houndmills, Basingstoke, England) 2011;17(5):567-77.
2011: Mohsen Khademi; Ingrid Kockum; Magnus L Andersson; Ellen Iacobaeus; Lou Brundin; Finn Sellebjerg; Jan Hillert; Fredrik Piehl; Tomas Olsson
Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course.
Multiple sclerosis (Houndmills, Basingstoke, England) 2011;17(3):335-43.
2011: D Hesse; Martin Krakauer; H Lund; Hans Søndergaard; S J W Limborg; Per Soelberg Sørensen; Finn Sellebjerg
Disease protection and interleukin-10 induction by endogenous interferon-β in multiple sclerosis?
European journal of neurology : the official journal of the European Federation of Neurological Societies 2011;18(2):266-72.
2011: Chris Juul Hedegaard; Christian Enevold; Finn Sellebjerg; Klaus Bendtzen; Claus Henrik Nielsen
Variation in NOD2 augments Th2- and Th17 responses to myelin basic protein in multiple sclerosis.
PloS one 2011;6(5):e20253.
2011: Bjørn A Nexø; Tove Christensen; Jette Frederiksen; Anné Møller-Larsen; Annette Oturai; Palle Villesen; Bettina Hansen; Kari K Nissen; Magdalena J Laska; Trine S Petersen; Sandra Bonnesen; Anne Hedemand; Tingting Wu; Xinjie Wang; Xiuqing Zhang; Tomasz Brudek; Romana Maric; Helle B Søndergaard; Finn Sellebjerg; Klaus Brusgaard; Anders L Kjeldbjerg; Henrik B Rasmussen; Anders L Nielsen; Mette Nyegaard; Thor Petersen; Anders D Børglum; Finn Skou Pedersen
The etiology of multiple sclerosis: genetic evidence for the involvement of the human endogenous retrovirus HERV-Fc1.
PloS one 2011;6(2):e16652.
2011: Lars Börnsen; Mohsen Khademi; Tomas Olsson; Per Soelberg Sørensen; Finn Sellebjerg
Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2011;17(1):32-42.
2010: D Hesse; Martin Krakauer; H Lund; Hans Søndergaard; Annika Reynberg Langkilde; lars peter ryder; Per Soelberg Sorensen; Finn Sellebjerg
Breakthrough disease during interferon-[beta] therapy in MS: No signs of impaired biologic response.
Neurology 2010;74(18):1455-62.
2010: Inger-Lise Mero; Aslaug R Lorentzen; Maria Ban; Cathrine Smestad; Elisabeth Gulowsen Celius; Jan H Aarseth; Kjell-Morten Myhr; Jenny Link; Jan Hillert; Tomas Olsson; Ingrid Kockum; Thomas Masterman; Annette Oturai; Helle Bach Søndergaard; Finn Sellebjerg; Janna Saarela; Anu Kemppinen; Irina Elovaara; Anne Spurkland; Frank Dudbridge; Benedicte Lie; Hanne F Harbo
A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis.
European journal of human genetics : EJHG 2010;18(4):502-4.
2009: Chris J Hedegaard; Ning Chen; Finn Sellebjerg; Per Soelberg Sørensen; Robert Graham Quinton Leslie; Klaus Bendtzen; Claus Henrik Nielsen
Autoantibodies to myelin basic protein (MBP) in healthy individuals and in patients with multiple sclerosis: a role in regulating cytokine responses to MBP.
Immunology 2009;128(1 Suppl):e451-61.
2009: D Hesse; Finn Sellebjerg; Per Soelberg Sorensen
Absence of MxA induction by interferon beta in patients with MS reflects complete loss of bioactivity.
Neurology 2009;73(5):372-7.
2009: Florian Deisenhammer; Robert Egg; G Giovannoni; B Hemmer; Axel Petzold; Finn Sellebjerg; C Teunissen; H Tumani
EFNS guidelines on disease-specific CSF investigations.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2009;16(6):760-70.
2008: Per Soelberg Sorensen; Finn Sellebjerg
Oral fumarate for relapsing-remitting multiple sclerosis.
Lancet 2008;372(9648):1447-8.
2008: Chris J Hedegaard; Martin Krakauer; Klaus Bendtzen; Per Soelberg Sørensen; Finn Sellebjerg; Claus H Nielsen
The effect of beta-interferon therapy on myelin basic protein-elicited CD4+ T cell proliferation and cytokine production in multiple sclerosis.
Clinical immunology (Orlando, Fla.) 2008;129(1):80-9.
2008: Chris J Hedegaard; Martin Krakauer; Klaus Bendtzen; Henrik Lund; Finn Sellebjerg; Claus Henrik Nielsen
T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis.
Immunology 2008;125(2):161-9.
2008: Per Soelberg Sørensen; Finn Sellebjerg
[Biological treatment of multiple sclerosis].
Ugeskrift for laeger 2008;170(24):2156-9.
2008: Martin Krakauer; P Sorensen; Mohsen Khademi; T Olsson; Finn Sellebjerg
Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression.
Multiple sclerosis (Houndmills, Basingstoke, England) 2008;14(5):622-30.
2008: Finn Sellebjerg; Annette Oturai; Per Soelberg Sørensen
[Multiple sclerosis--the significance of genes. The Danish Society of Neurology].
Ugeskrift for laeger 2008;170(12):1046.
2007: Hans-P Hartung; Chris H Polman; Antonio Bertolotto; Florian Deisenhammer; Gavin Giovannoni; Eva Havrdova; Bernhard Hemmer; Jan Hillert; Ludwig Kappos; Bernd C Kieseier; Joep Killestein; Christophe Malcus; Manuel Comabella; Andrew R Pachner; Huub Schellekens; Finn Sellebjerg; Krzysztof Selmaj; Per Soelberg Sorensen
Neutralising antibodies to interferon beta in multiple sclerosis : expert panel report.
Journal of neurology 2007;254(7):827-37.
2007: Finn Sellebjerg; Thomas Birk kristiansen; P Wittenhagen; P Garred; Jesper Eugen-Olsen; Jette Lautrup Frederiksen; Torben Lykke Sørensen
Chemokine receptor CCR5 in interferon-treated multiple sclerosis.
Acta neurologica Scandinavica 2007;115(6):413-8.
2007: Finn Sellebjerg; Per Soelberg Sørensen
[Treatment of multiple sclerosis--now and in future. The Danish Multiple Sclerosis Society and the Danish Multiple Sclerosis Group].
Ugeskrift for laeger 2007;169(12):1121.
2006: Martin Krakauer; Per Soelberg Sorensen; Finn Sellebjerg
CD4(+) memory T cells with high CD26 surface expression are enriched for Th1 markers and correlate with clinical severity of multiple sclerosis.
Journal of neuroimmunology 2006;181(1-2):157-64.
2006: J Jensen; Annika Reynberg Langkilde; Jette Lautrup Frederiksen; Finn Sellebjerg
CD8+ T cell activation correlates with disease activity in clinically isolated syndromes and is regulated by interferon-beta treatment.
Journal of neuroimmunology 2006;179(1-2):163-72.
2006: Florian Deisenhammer; A Bartos; Robert Egg; N E Gilhus; G Giovannoni; S Rauer; Finn Sellebjerg
Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2006;13(9):913-22.
2006: Martin Krakauer; Per Soelberg Sorensen; Mohsen Khademi; T Olsson; Finn Sellebjerg
Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis.
Scandinavian journal of immunology 2006;64(2):155-63.
2006: Birgitte Stoevring; Irakli Jaliashvili; Annemette Vinding Thougaard; Christian Ensinger; Claus K Høgdall; Lars S Rasmussen; Finn Sellebjerg; Michael Christiansen
Tetranectin in cerebrospinal fluid of patients with multiple sclerosis.
Scandinavian journal of clinical and laboratory investigation 2006;66(7):577-83.
2005: Finn Sellebjerg; D Barnes; G Filippini; R Midgard; X Montalban; P Rieckmann; Krzysztof Selmaj; L H Visser; Per Soelberg Sørensen
EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2005;12(12):939-46.
2005: Finn Sellebjerg; C Ross; Nils Koch-Henriksen; Per Soelberg Sørensen; Jette Lautrup Frederiksen; Klaus Bendtzen; Torben Lykke Sørensen
CD26 + CD4 + T cell counts and attack risk in interferon-treated multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2005;11(6):641-5.
2005: Ee Tuan Lim; Finn Sellebjerg; CV Jensen; Daniel R Altmann; D Grant; Geoff Keir; Edward J Thompson; Gavin Giovannoni
Acute axonal damage predicts clinical outcome in patients with multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2005;11(5):532-6.
2005: Birgitte Stoevring; Irakli Jaliashvili; Annemette Vinding Thougaard; Christian Ensinger; Claus K Høgdall; Lars S Rasmussen; Finn Sellebjerg; Michael Christiansen
Tetranectin in cerebrospinal fluid: biochemical characterisation and evidence of intrathecal synthesis or selective uptake into CSF.
Clinica chimica acta; international journal of clinical chemistry 2005;359(1-2):65-71.
2005: Mark S Freedman; Edward J Thompson; Florian Deisenhammer; Gavin Giovannoni; Guy Grimsley; Geoff Keir; Sten Ohman; Michael K Racke; Mohammad Sharief; C J M Sindic; Finn Sellebjerg; Wallace W Tourtellotte
Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement.
Archives of neurology 2005;62(6):865-70.
2005: Hanne Roed; Jette Lautrup Frederiksen; Annika Reynberg Langkilde; Torben Lykke Sørensen; Martin Lauritzen; Finn Sellebjerg
Systemic T-cell activation in acute clinically isolated optic neuritis.
Journal of neuroimmunology 2005;162(1-2):165-72.
2005: Hanne Roed; Annika Reynberg Langkilde; Finn Sellebjerg; Martin Lauritzen; P Bang; A Mørup; Jette Lautrup Frederiksen
A double-blind, randomized trial of IV immunoglobulin treatment in acute optic neuritis.
Neurology 2005;64(5):804-10.
2005: Mads Ravnborg; Morten Blinkenberg; Finn Sellebjerg; M Ballegaard; S Helweg Larsen; Per Soelberg Sørensen
Responsiveness of the Multiple Sclerosis Impairment Scale in comparison with the Expanded Disability Status Scale.
Multiple sclerosis (Houndmills, Basingstoke, England) 2005;11(1):81-4.
2005: Jakob Jensen; Martin Krakauer; Finn Sellebjerg
Cytokines and adhesion molecules in multiple sclerosis patients treated with interferon-beta1b.
Cytokine 2005;29(1):24-30.
2004: Per Soelberg Sorensen; J Haas; Finn Sellebjerg; T Olsson; Mads Ravnborg
IV immunoglobulins as add-on treatment to methylprednisolone for acute relapses in MS.
Neurology 2004;63(11):2028-33.
2004: Torben Lykke Sørensen; Hanne Roed; Finn Sellebjerg
Optic neuritis: chemokine receptor CXCR3 and its ligands.
The British journal of ophthalmology 2004;88(9):1146-8.
2004: Torben Lykke Sørensen; Richard M Ransohoff; Robert M Strieter; Finn Sellebjerg
Chemokine CCL2 and chemokine receptor CCR2 in early active multiple sclerosis.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2004;11(7):445-9.
2004: Finn Sellebjerg
Methylprednisolone treatment, immune activation, and intrathecal inflammation in multiple sclerosis.
Danish medical bulletin 2004;51(2):167-83.
2004: J Jensen; Annika Reynberg Langkilde; C Fenst; M S Nicolaisen; Hanne Roed; M Christiansen; Finn Sellebjerg
CD4 T cell activation and disease activity at onset of multiple sclerosis.
Journal of neuroimmunology 2004;149(1-2):202-9.
2003: Torben Lykke Sørensen; Richard M Ransohoff; J Jensen; Finn Sellebjerg
Evidence favoring the involvement of CC chemokine receptor (CCR) 5 in T-lymphocyte accumulation in optic neuritis.
Acta neurologica Scandinavica 2003;107(3):221-7.
2003: Finn Sellebjerg; CV Jensen; Henrik B W Larsson; Jette Lautrup Frederiksen
Gadolinium-enhanced magnetic resonance imaging predicts response to methylprednisolone in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2003;9(1):102-7.
2002: Finn Sellebjerg; J Jensen; CV Jensen; A Wiik
Expansion of CD5 - B cells in multiple sclerosis correlates with CD80 (B7-1) expression.
Scandinavian journal of immunology 2002;56(1):101-7.
2002: Torben Lykke Sørensen; Corinna Trebst; Pia Kivisäkk; Karen L Klaege; Amit Majmudar; Rivka Ravid; Hans Lassmann; David B Olsen; Robert M Strieter; Richard M Ransohoff; Finn Sellebjerg
Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system.
Journal of neuroimmunology 2002;127(1-2):59-68.
2002: Torben Lykke Sørensen; Finn Sellebjerg
Selective suppression of chemokine receptor CXCR3 expression by interferon-beta1a in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2002;8(2):104-7.
2002: Finn Sellebjerg; Gavin Giovannoni; A Hand; HO Madsen; CV Jensen; Peter Garred
Cerebrospinal fluid levels of nitric oxide metabolites predict response to methylprednisolone treatment in multiple sclerosis and optic neuritis.
Journal of neuroimmunology 2002;125(1-2):198-203.
2002: Corinna Trebst; Torben Lykke Sørensen; Pia Kivisäkk; Martha K Cathcart; Joseph Hesselgesser; Richard Horuk; Finn Sellebjerg; Hans Lassmann; Richard M Ransohoff
Chemokine receptors on mononuclear phagocytes in the central nervous system of patients with multiple sclerosis.
Ernst Schering Research Foundation workshop 2002;(39):193-211.
2002: Torben Lykke Sørensen; Hanne Roed; Finn Sellebjerg
Chemokine receptor expression on B cells and effect of interferon-beta in multiple sclerosis.
Journal of neuroimmunology 2002;122(1-2):125-31.
2001: Torben Lykke Sørensen; Finn Sellebjerg; CV Jensen; Robert M Strieter; Richard M Ransohoff
Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2001;8(6):665-72.
2001: Corinna Trebst; Torben Lykke Sørensen; Pia Kivisäkk; Martha K Cathcart; Joseph Hesselgesser; Richard Horuk; Finn Sellebjerg; Hans Lassmann; Richard M Ransohoff
CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis.
The American journal of pathology 2001;159(5):1701-10.
2001: Torben Lykke Sørensen; Finn Sellebjerg
Distinct chemokine receptor and cytokine expression profile in secondary progressive MS.
Neurology 2001;57(8):1371-6.
2001: J Jensen; Martin Krakauer; Finn Sellebjerg
Increased T cell expression of CD154 (CD40-ligand) in multiple sclerosis.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2001;8(4):321-8.
2000: Deborah M Miller; Bianca Weinstock-Guttman; F Béthoux; Jar-Chi Lee; G Beck; V Block; L Durelli; L LaMantia; D Barnes; Finn Sellebjerg; Richard A Rudick
A meta-analysis of methylprednisolone in recovery from multiple sclerosis exacerbations.
Multiple sclerosis (Houndmills, Basingstoke, England) 2000;6(4):267-73.
2000: Finn Sellebjerg; CV Jensen; Michael Christiansen
Intrathecal IgG synthesis and autoantibody-secreting cells in multiple sclerosis.
Journal of neuroimmunology 2000;108(1-2):207-15.
2000: Finn Sellebjerg; Michael Christiansen; J Jensen; Jette Lautrup Frederiksen
Immunological effects of oral high-dose methylprednisolone in acute optic neuritis and multiple sclerosis.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2000;7(3):281-9.
2000: Finn Sellebjerg; J Jensen; HO Madsen; A Svejgaard
HLA DRB1*1501 and intrathecal inflammation in multiple sclerosis.
Tissue antigens 2000;55(4):312-8.
2000: Finn Sellebjerg; HO Madsen; CV Jensen; J Jensen; Peter Garred
CCR5 delta32, matrix metalloproteinase-9 and disease activity in multiple sclerosis.
Journal of neuroimmunology 2000;102(1):98-106.
1999: Finn Sellebjerg; Jette Lautrup Frederiksen; PM Nielsen; Jes Olesen
[Randomized controlled trial of high-dose peroral methylprednisolone in attacks of multiple sclerosis].
Ugeskrift for laeger 1999;161(48):6625-9.
1999: Finn Sellebjerg; Henriette S Nielsen; Jette Lautrup Frederiksen; Jes Olesen
A randomized, controlled trial of oral high-dose methylprednisolone in acute optic neuritis.
Neurology 1999;52(7):1479-84.
1999: Torben Lykke Sørensen; Marie Tani; J Jensen; V Pierce; Claudia F Lucchinetti; VA Folcik; S Qin; J Rottman; Finn Sellebjerg; Robert M Strieter; Jette Lautrup Frederiksen; Richard M Ransohoff
Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients.
The Journal of clinical investigation 1999;103(6):807-15.
1998: Finn Sellebjerg; Michael Christiansen; PM Nielsen; Jette Lautrup Frederiksen
Cerebrospinal fluid measures of disease activity in patients with multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 1998;4(6):475-9.
1998: Martin Krakauer; H Schaldemose Nielsen; J Jensen; Finn Sellebjerg
Intrathecal synthesis of free immunoglobulin light chains in multiple sclerosis.
Acta neurologica Scandinavica 1998;98(3):161-5.
1998: Finn Sellebjerg; Jette Lautrup Frederiksen; PM Nielsen; Jes Olesen
Double-blind, randomized, placebo-controlled study of oral, high-dose methylprednisolone in attacks of MS.
Neurology 1998;51(2):529-34.
1998: AA Petersen; Finn Sellebjerg; Jette Lautrup Frederiksen; J Olesen; G L Vejlsgaard
Soluble ICAM-1, demyelination, and inflammation in multiple sclerosis and acute optic neuritis.
Journal of neuroimmunology 1998;88(1-2):120-7.
1998: Finn Sellebjerg; Michael Christiansen; Peter Garred
MBP, anti-MBP and anti-PLP antibodies, and intrathecal complement activation in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 1998;4(3):127-31.
1998: Finn Sellebjerg; Irakli Jaliashvili; Michael Christiansen; Peter Garred
Intrathecal activation of the complement system and disability in multiple sclerosis.
Journal of the neurological sciences 1998;157(2):168-74.
1998: Finn Sellebjerg; J Jensen; lars peter ryder
Costimulatory CD80 (B7-1) and CD86 (B7-2) on cerebrospinal fluid cells in multiple sclerosis.
Journal of neuroimmunology 1998;84(2):179-87.
1997: Jette Lautrup Frederiksen; Torben Lykke Sørensen; Finn Sellebjerg
Residual symptoms and signs after untreated acute optic neuritis. A one-year follow-up.
Acta ophthalmologica Scandinavica 1997;75(5):544-7.
1996: Finn Sellebjerg; Michael Christiansen
Qualitative assessment of intrathecal IgG synthesis by isoelectric focusing and immunodetection: interlaboratory reproducibility and interobserver agreement.
Scandinavian journal of clinical and laboratory investigation 1996;56(2):135-43.
1996: Jette Lautrup Frederiksen; Jes Olesen; Henrik B W Larsson; J Petrera; Finn Sellebjerg
Acute unilateral papillitis versus retrobulbar neuritis: relation to multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 1996;1(4):223-7.
1995: Finn Sellebjerg; H O Madsen; Jette Lautrup Frederiksen; lars peter ryder; Arne Svejgaard
Acute optic neuritis: myelin basic protein and proteolipid protein antibodies, affinity, and the HLA system.
Annals of neurology 1995;38(6):943-50.
1994: Finn Sellebjerg; Jette Lautrup Frederiksen; T Olsson
Anti-myelin basic protein and anti-proteolipid protein antibody-secreting cells in the cerebrospinal fluid of patients with acute optic neuritis.
Archives of neurology 1994;51(10):1032-6.
1994: Finn Sellebjerg; Jette Lautrup Frederiksen; T Olsson; H Link; H O Madsen; lars peter ryder; Arne Svejgaard
Peptide specificity of anti-myelin basic protein antibodies in patients with acute optic neuritis and the HLA system.
Scandinavian journal of immunology 1994;39(6):575-80.
1993: Finn Sellebjerg; Jette Lautrup Frederiksen
[IGG index or oligoclonal bands in the diagnosis of disseminated sclerosis].
Ugeskrift for laeger 1993;155(8):558-60.